RANI (STOCKS)
Rani Therapeutics Holdings, Inc. Class A Common Stock
$0.810000
+0.007200 (+0.90%)
Prev close: $0.802800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Talat Imran
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $109.93M
- Employees
- 106
- P/E (TTM)
- -1.95
- P/B (TTM)
- 2.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.04 | $-0.05 | +0.0059 | +12.85% |
|
Dec 2025 (Q4)
|
$-0.07 | $-0.07 | -0.0020 | -2.94% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.13 | +0.0058 | +4.61% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.20 | +0.0189 | +9.50% |
Financial Statements
| Revenues | $3.17M |
| Benefits Costs and Expenses | $39.40M |
| Costs And Expenses | $39.40M |
| Operating Expenses | $37.81M |
| Depreciation and Amortization | $810.00K |
| Research and Development | $18.80M |
| Other Operating Expenses | $18.66M |
| Operating Income/Loss | -$34.64M |
| Income/Loss From Continuing Operations After Tax | -$36.23M |
| Income/Loss From Continuing Operations Before Tax | -$36.23M |
| Interest Expense, Operating | $2.04M |
| Net Income/Loss | -$36.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$6.79M |
| Net Income/Loss Attributable To Parent | -$29.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.29 |
| Diluted Earnings Per Share | -$0.29 |
| Basic Average Shares | 224,192,138 |
| Diluted Average Shares | 224,192,138 |
| Assets | $51.88M |
| Current Assets | $47.09M |
| Prepaid Expenses | $1.65M |
| Other Current Assets | $45.45M |
| Noncurrent Assets | $4.79M |
| Fixed Assets | $601.00K |
| Other Non-current Assets | $4.19M |
| Liabilities | $16.34M |
| Current Liabilities | $13.86M |
| Accounts Payable | $858.00K |
| Other Current Liabilities | $13.00M |
| Noncurrent Liabilities | $2.48M |
| Equity | $35.54M |
| Equity Attributable To Noncontrolling Interest | $7.14M |
| Equity Attributable To Parent | $28.41M |
| Liabilities And Equity | $51.88M |
| Net Cash Flow From Operating Activities | -$17.06M |
| Net Cash Flow From Operating Activities, Continuing | -$17.06M |
| Net Cash Flow From Investing Activities | -$27.71M |
| Net Cash Flow From Investing Activities, Continuing | -$27.71M |
| Net Cash Flow From Financing Activities | $44.00M |
| Net Cash Flow From Financing Activities, Continuing | $44.00M |
| Net Cash Flow | -$767.00K |
| Net Cash Flow, Continuing | -$767.00K |
| Comprehensive Income/Loss | -$36.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$6.50M |
| Comprehensive Income/Loss Attributable To Parent | -$29.74M |
| Other Comprehensive Income/Loss | -$11.00K |